National Cancer Institute (nci)
Clinical trials sponsored by National Cancer Institute (nci), explained in plain language.
-
New Two-Drug combo tested in battle against stubborn blood cancer
Disease control Not yet recruitingThis study aims to see if a new two-drug combination (daratumumab + teclistamab) works better than current standard drug combinations for people with multiple myeloma that has come back or stopped responding to their first treatment. It will enroll about 80 adults and measure how…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 22, 2026 15:58 UTC
-
New targeted therapy battles recurrent ovarian cancer in major trial
Disease control Not yet recruitingThis study is for people whose ovarian cancer has returned after initially responding to platinum-based chemotherapy and has progressed while on a specific type of maintenance therapy (a PARP inhibitor). It aims to see if a newer drug combination (sacituzumab govitecan plus bevac…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 13, 2026 20:18 UTC